Genome engineering: a new approach to gene therapy for neuromuscular disorders.
about
Vaccine against PCSK9: the natural strategy from passive to active immunization for the prevention of atherosclerosis.Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis.Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.
P2860
Genome engineering: a new approach to gene therapy for neuromuscular disorders.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Genome engineering: a new approach to gene therapy for neuromuscular disorders.
@en
type
label
Genome engineering: a new approach to gene therapy for neuromuscular disorders.
@en
prefLabel
Genome engineering: a new approach to gene therapy for neuromuscular disorders.
@en
P2860
P1476
Genome engineering: a new approach to gene therapy for neuromuscular disorders
@en
P2093
Charles A Gersbach
Jacqueline N Robinson-Hamm
P2860
P2888
P304
P356
10.1038/NRNEUROL.2017.126
P407
P577
2017-09-29T00:00:00Z